{"count": 6, "results": [{"_id": "39892994", "pmid": 39892994, "title": "Metformin finding its way into the central nervous system: Combating neurological diseases?", "journal": "J Pharmacol Exp Ther", "authors": ["Cignarella A", "Lin Q", "Bae M"], "date": "2025-01-01T00:00:00Z", "doi": "10.1016/j.jpet.2024.100042", "meta_date_publication": "2025 Jan", "meta_volume": "392", "meta_issue": "1", "meta_pages": "100042", "score": 50274.223, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ finding its way into the central nervous system: Combating @<m>DISEASE_Heredodegenerative_Disorders_Nervous_System</m> @DISEASE_MESH:D020271 @@@neurological diseases@@@?", "citations": {"NLM": "Cignarella A, Lin Q, Bae M. Metformin finding its way into the central nervous system: Combating neurological diseases? J Pharmacol Exp Ther. 2025 Jan;392(1):100042. PMID: 39892994", "BibTeX": "@article{39892994, title={Metformin finding its way into the central nervous system: Combating neurological diseases?}, author={Cignarella A and Lin Q and Bae M}, journal={J Pharmacol Exp Ther}, volume={392}, number={1}, pages={100042}}"}}, {"_id": "33161784", "pmid": 33161784, "pmcid": "PMC9482886", "title": "Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system", "journal": "Expert Rev Neurother", "authors": ["Demaré S", "Kothari A", "Calcutt NA", "Fernyhough P"], "date": "2021-01-01T00:00:00Z", "doi": "10.1080/14737175.2021.1847645", "meta_date_publication": "2021 Jan", "meta_volume": "21", "meta_issue": "1", "meta_pages": "45-63", "score": 50267.47, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as a potential therapeutic for @<m>DISEASE_Heredodegenerative_Disorders_Nervous_System</m> @DISEASE_MESH:D020271 @@@neurological disease@@@: mobilizing @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ to repair the nervous system", "citations": {"NLM": "Demaré S, Kothari A, Calcutt NA, Fernyhough P. Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system Expert Rev Neurother. 2021 Jan;21(1):45-63. PMID: 33161784", "BibTeX": "@article{33161784, title={Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system}, author={Demaré S and Kothari A and Calcutt NA and Fernyhough P}, journal={Expert Rev Neurother}, volume={21}, number={1}, pages={45-63}}"}}, {"_id": "34069559", "pmid": 34069559, "pmcid": "PMC8160983", "title": "Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease", "journal": "Int J Mol Sci", "authors": ["Sanz P", "Serratosa JM", "Sánchez MP"], "date": "2021-05-19T00:00:00Z", "doi": "10.3390/ijms22105351", "meta_date_publication": "2021 May 19", "meta_volume": "22", "meta_issue": "10", "meta_pages": "", "score": 50261.074, "text_hl": "In this work, we will review the different proposed mechanisms of action of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and the beneficial effect that this drug has as a neuroprotective agent in different @<m>DISEASE_Heredodegenerative_Disorders_Nervous_System</m> @DISEASE_MESH:D020271 @@@neurological diseases@@@, with special attention to @DISEASE_Congenital_Hereditary_and_Neonatal_Diseases_and_Abnormalities @DISEASE_MESH:D009358 @@@epileptic disorders@@@ and @DISEASE_Lafora_Disease @DISEASE_MESH:D020192 @@@Lafora disease@@@, a form of progressive @DISEASE_Epilepsies_Myoclonic @DISEASE_MESH:D004831 @@@myoclonus epilepsy@@@ (see below).", "citations": {"NLM": "Sanz P, Serratosa JM, Sánchez MP. Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease Int J Mol Sci. 2021 May 19;22(10):. PMID: 34069559", "BibTeX": "@article{34069559, title={Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease}, author={Sanz P and Serratosa JM and Sánchez MP}, journal={Int J Mol Sci}, volume={22}, number={10}}"}}, {"_id": "31751298", "pmid": 31751298, "title": "Could metformin be therapeutically useful in Huntington's disease?", "journal": "Rev Neurosci", "authors": ["Tang BL"], "date": "2020-04-28T00:00:00Z", "doi": "10.1515/revneuro-2019-0072", "meta_date_publication": "2020 Apr 28", "meta_volume": "31", "meta_issue": "3", "meta_pages": "297-317", "score": 50255.977, "text_hl": "In this regard, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may nonetheless be therapeutically useful for @<m>DISEASE_Heredodegenerative_Disorders_Nervous_System</m> @DISEASE_MESH:D020271 @@@neurological diseases@@@ with early pathological onsets, such as @DISEASE_Huntington_Disease @DISEASE_MESH:D006816 @@@HD@@@.", "citations": {"NLM": "Tang BL. Could metformin be therapeutically useful in Huntington's disease? Rev Neurosci. 2020 Apr 28;31(3):297-317. PMID: 31751298", "BibTeX": "@article{31751298, title={Could metformin be therapeutically useful in Huntington's disease?}, author={Tang BL}, journal={Rev Neurosci}, volume={31}, number={3}, pages={297-317}}"}}, {"_id": "36244266", "pmid": 36244266, "title": "Mechanism of metformin regulation in central nervous system: Progression and future perspectives.", "journal": "Biomed Pharmacother", "authors": ["Cao G", "Gong T", "Du Y", "Wang Y", "Ge T", "Liu J"], "date": "2022-12-01T00:00:00Z", "doi": "10.1016/j.biopha.2022.113686", "meta_date_publication": "2022 Dec", "meta_volume": "156", "meta_issue": "", "meta_pages": "113686", "score": 50254.94, "text_hl": "These findings indicate there might be extensive pharmacological efficacy and therapeutic insights of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Heredodegenerative_Disorders_Nervous_System</m> @DISEASE_MESH:D020271 @@@neurological diseases@@@' clinical application.", "citations": {"NLM": "Cao G, Gong T, Du Y, Wang Y, Ge T, Liu J. Mechanism of metformin regulation in central nervous system: Progression and future perspectives. Biomed Pharmacother. 2022 Dec;156():113686. PMID: 36244266", "BibTeX": "@article{36244266, title={Mechanism of metformin regulation in central nervous system: Progression and future perspectives.}, author={Cao G and Gong T and Du Y and Wang Y and Ge T and Liu J}, journal={Biomed Pharmacother}, volume={156}, pages={113686}}"}}, {"_id": "34042039", "pmid": 34042039, "title": "Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models.", "journal": "CNS Neurol Disord Drug Targets", "authors": ["Nikbakhtzadeh M", "Shaerzadeh F", "Ashabi G"], "date": "2021-01-01T00:00:00Z", "doi": "10.2174/1871527320666210526160214", "meta_date_publication": "2021", "meta_volume": "20", "meta_issue": "9", "meta_pages": "786-801", "score": 50231.547, "text_hl": "More specifically, we review the neuroprotective or neurodegenerative effects of @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ or @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activators like @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Resveratrol @CHEMICAL_MESH:D000077185 @@@resveratrol@@@, and @CHEMICAL_acadesine @CHEMICAL_MESH:C011651 @@@5-aminoimidazole-4-carboxamide- 1-beta-d-ribofuranoside@@@ on @<m>DISEASE_Heredodegenerative_Disorders_Nervous_System</m> @DISEASE_MESH:D020271 @@@neurological diseases@@@ and @DISEASE_Dementia @DISEASE_MESH:D003704 @@@dementia@@@, which exert through the intracellular molecules involved in neuronal survival or death.", "citations": {"NLM": "Nikbakhtzadeh M, Shaerzadeh F, Ashabi G. Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models. CNS Neurol Disord Drug Targets. 2021;20(9):786-801. PMID: 34042039", "BibTeX": "@article{34042039, title={Highlighting the Protective or Degenerative Role of AMPK Activators in Dementia Experimental Models.}, author={Nikbakhtzadeh M and Shaerzadeh F and Ashabi G}, journal={CNS Neurol Disord Drug Targets}, volume={20}, number={9}, pages={786-801}}"}}]}